Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro

Frank Tacke; Elham Shirvani-Dastgerdi

doi:10.5812/hepatmon.6131

https://doi.org/10.5812/hepatmon.6131

Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro

authors:

Frank Tacke ^{1
, *} , Elham Shirvani-Dastgerdi ²

1 Department of Medicine III, University Hospital Aachen, frank.tacke@gmx.net, Germany

2 Department of Medicine III, University Hospital Aachen, Germany

Hepatitis Monthly: Vol.12, issue 6; 357-360

article type: Editorial

received: February 12, 2012

accepted: April 11, 2012

How To Cite Tacke F, Shirvani-Dastgerdi E. Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro. Hepat Mon. 2012;12(6): 357-360. https://doi.org/10.5812/hepatmon.6131.

Abstract

This article does not have abstract.

Keywords

Hepatitis B e Antigens HBV Precore Basal Core Promoter Drug Resistance

Full Text

Full text is available in PDF

comments

Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro

Abstract

Keywords

Full Text

Cookie Setting